×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [16]
合肥物质科学研究院 [11]
广州生物医药与健康研... [2]
北京大学 [1]
西安交通大学 [1]
大连理工大学 [1]
更多...
内容类型
期刊论文 [35]
发表日期
2019 [2]
2018 [4]
2017 [12]
2016 [3]
2014 [2]
2013 [5]
更多...
学科主题
Pharmacolo... [2]
Oncology; ... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共35条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry
期刊论文
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 卷号: 176, 页码: 6
作者:
Liu, Xiaoyun
;
Li, Wei
;
Zhang, Yifan
;
Jian, Yong
;
Zhao, Qianyu
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2020/07/01
LC-MS/MS
Alflutinib
AST2818
Pharmacokinetics
Human plasma
Synthesis and Biological Evaluation of Oxopyrido[2,3-d] Pyrimidine-7-ones Derivatives as Covalent L85812/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors
期刊论文
LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 卷号: 16, 期号: 8, 页码: 826-834
作者:
Niu, Ao
;
Wang, Yang
;
Yang, Yushe
;
Wei, Jianhai
;
Ding, Jian
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/07/01
Non-small cell lung cancer
irreversible inhibitors
EGFR(T79014)( )mutant
anti-tumor
xenograft model
cell proliferation
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 13, 页码: 5609-5622
作者:
Hao, Yongjia
;
Lyu, Jiankun
;
Qu, Rong
;
Tong, Yi
;
Sun, Deheng
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2019/01/08
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo
期刊论文
CANCER MEDICINE, 2018, 卷号: 7, 期号: 4, 页码: 1430-1439
作者:
Zhang, Zhang
;
Zou, Jian
;
Yu, Lei
;
Luo, Jinfeng
;
Li, Yan
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2019/01/08
EGFR inhibitor
lung cancer
pharmacokinetic
selectively
T790M mutation
Allenamide as a bioisostere of acrylamide in the design and synthesis of targeted covalent inhibitors
期刊论文
MEDCHEMCOMM, 2018, 卷号: 9, 期号: 2, 页码: 244-253
作者:
Chen, Deheng
;
Guo, Dexiang
;
Yan, Ziqin
;
Zhao, Yujun
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/01/08
Synthesis and biological evaluation of irreversible EGFR tyrosine kinase inhibitors containing pyrido[3,4-d]pyrimidine scaffold
期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 卷号: 26, 页码: 3619-3633
作者:
Zhang, Hao
;
Wang, Jin
;
Zhao, Hong-Yi
;
Yang, Xue-Yan
;
Lei, Hao
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/11/26
Pyrido[3,4-d]pyrimidine
Anticancer
Drug design
Irreversible inhibitors
EGFR-TKIs
Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 140, 页码: 510-527
作者:
Chen, Lingfeng
;
Fu, Weitao
;
Feng, Chen
;
Qu, Rong
;
Tong, Linjiang
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2019/01/08
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Non-small cell lung cancer
T790M
Mutant-selective
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl) phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 131, 页码: 107-125
作者:
Liang, Qianmao
;
Chen, Yongfei
;
Yu, Kailin
;
Chen, Cheng
;
Zhang, Shouxiang
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2018/07/26
Btk
Irreversible Inhibitor
Kinase Inhibitor
Structure-activity Relationship
B-cell Lymphoma
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2018/07/26
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2018/07/26
©版权所有 ©2017 CSpace - Powered by
CSpace